LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 669

Search options

  1. Article ; Online: COVID-19 in systemic vasculitis and polymyalgia rheumatica: who is at risk of poor outcomes?

    Monti, Sara

    The Lancet. Rheumatology

    2021  Volume 3, Issue 12, Page(s) e823–e824

    Language English
    Publishing date 2021-11-05
    Publishing country England
    Document type Journal Article
    ISSN 2665-9913
    ISSN (online) 2665-9913
    DOI 10.1016/S2665-9913(21)00357-X
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Humoral and T-cell immune response following three doses of SARS-CoV-2 mRNA vaccine in giant cell arteritis: analysis of a prospective cohort.

    Bartoletti, Alice / Fornara, Chiara / Delvino, Paolo / Franchi, Giulia / Ferrari, Alessandro / Baldanti, Fausto / Montecucco, Carlomaurizio / Monti, Sara

    Clinical and experimental rheumatology

    2023  

    Language English
    Publishing date 2023-09-15
    Publishing country Italy
    Document type Letter
    ZDB-ID 605886-3
    ISSN 1593-098X ; 0392-856X
    ISSN (online) 1593-098X
    ISSN 0392-856X
    DOI 10.55563/clinexprheumatol/mlatyf
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Correspondence on 'EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update' by Hellmich

    Robson, Joanna C / Díaz Encarnación, Montserrat M / Verhoeven, Peter / Olivenza Antón, Raquel / Balcells-Oliver, Monica / Popov, Tamara / Monti, Sara / Kronbichler, Andreas

    Annals of the rheumatic diseases

    2024  

    Language English
    Publishing date 2024-02-22
    Publishing country England
    Document type Letter
    ZDB-ID 7090-7
    ISSN 1468-2060 ; 0003-4967
    ISSN (online) 1468-2060
    ISSN 0003-4967
    DOI 10.1136/ard-2024-225583
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Response to: 'Increased rather than decreased incidence of giant-cell arteritis during the COVID-19 pandemic' by Lecler

    Monti, Sara / Montecucco, Carlomaurizio

    Annals of the rheumatic diseases

    2020  Volume 80, Issue 6, Page(s) e90

    MeSH term(s) COVID-19 ; Giant Cell Arteritis/epidemiology ; Humans ; Incidence ; Pandemics
    Keywords covid19
    Language English
    Publishing date 2020-09-22
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 7090-7
    ISSN 1468-2060 ; 0003-4967
    ISSN (online) 1468-2060
    ISSN 0003-4967
    DOI 10.1136/annrheumdis-2020-218634
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Azathioprine vs methotrexate in eosinophilic granulomatosis with polyangiitis: a monocentric retrospective study.

    Milanesi, Alessandra / Delvino, Paolo / Quaglini, Silvana / Montecucco, Carlomaurizio / Monti, Sara

    Rheumatology (Oxford, England)

    2023  Volume 63, Issue 4, Page(s) 945–952

    Abstract: Objectives: To analyse the effectiveness, safety and steroid-sparing effect of AZA and MTX as induction of remission and maintenance treatment in eosinophilic granulomatosis with polyangiitis.: Methods: We retrospectively collected data from 57 ... ...

    Abstract Objectives: To analyse the effectiveness, safety and steroid-sparing effect of AZA and MTX as induction of remission and maintenance treatment in eosinophilic granulomatosis with polyangiitis.
    Methods: We retrospectively collected data from 57 patients divided into four groups according to treatment: MTX/AZA as first-line agents (MTX1/AZA1) in non-severe disease or as second-line maintenance therapy (MTX2/AZA2) in severe disease previously treated with CYC/rituximab. During the first 5 years of treatment with AZA/MTX we compared the groups according to: remission rate [defined as R1: BVAS = 0; R2: BVAS = 0 with prednisone ≤5 mg/day; R3 (MIRRA definition): BVAS = 0 with prednisone ≤3.75 mg/day], persistence on therapy, cumulative glucocorticoid (GC) dose, relapse and adverse events (AEs).
    Results: There were no significant differences in remission rates (R1) in each group (63% in MTX1 vs 75% in AZA1, P = 0.53; 91% in MTX2 vs 71% in AZA2, P = 0.23). MTX1 allowed R2 more frequently in the first 6 months compared with AZA1 (54% vs 12%, P = 0.04); no patients receiving AZA1 achieved R3 up to the first 18 months (vs 35% in MTX1, P = 0.07). The cumulative GC dose was lower for MTX2 vs AZA2 (6 g vs 10.7 g at 5 years, P = 0.03). MTX caused more AEs compared with AZA (66% vs 30%, P = 0.004), without affecting the suspension rate. No differences emerged in time-to-first relapse, although fewer patients treated with AZA2 had asthma/ENT relapses (23% vs 64%, P = 0.04).
    Conclusion: A significant proportion of patients achieved remission with both MTX and AZA. MTX1 had an earlier remission on a lower GC dose but MTX2 had a better steroid-sparing effect.
    MeSH term(s) Humans ; Azathioprine/therapeutic use ; Methotrexate/therapeutic use ; Immunosuppressive Agents/therapeutic use ; Retrospective Studies ; Churg-Strauss Syndrome/drug therapy ; Prednisone/therapeutic use ; Granulomatosis with Polyangiitis/drug therapy ; Treatment Outcome ; Remission Induction ; Glucocorticoids/therapeutic use ; Recurrence
    Chemical Substances Azathioprine (MRK240IY2L) ; Methotrexate (YL5FZ2Y5U1) ; Immunosuppressive Agents ; Prednisone (VB0R961HZT) ; Glucocorticoids
    Language English
    Publishing date 2023-06-01
    Publishing country England
    Document type Journal Article
    ZDB-ID 1464822-2
    ISSN 1462-0332 ; 1462-0324
    ISSN (online) 1462-0332
    ISSN 1462-0324
    DOI 10.1093/rheumatology/kead302
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Non-steroidal anti-inflammatory treatment during covid-19: friend or foe? Response to: 'Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)' by Giollo

    Monti, Sara / Montecucco, Carlomaurizio

    Annals of the rheumatic diseases

    2020  Volume 80, Issue 2, Page(s) e13

    MeSH term(s) Anti-Inflammatory Agents, Non-Steroidal/therapeutic use ; COVID-19 ; Humans ; Inflammation/drug therapy ; Pharmaceutical Preparations ; SARS-CoV-2
    Chemical Substances Anti-Inflammatory Agents, Non-Steroidal ; Pharmaceutical Preparations
    Keywords covid19
    Language English
    Publishing date 2020-04-30
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 7090-7
    ISSN 1468-2060 ; 0003-4967
    ISSN (online) 1468-2060
    ISSN 0003-4967
    DOI 10.1136/annrheumdis-2020-217638
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Prevalence of COVID-19 among patients with rheumatic diseases: the need to await results from large collaborative studies. Response to: 'COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs' by Conticini

    Monti, Sara / Montecucco, Carlomaurizio

    Annals of the rheumatic diseases

    2020  Volume 80, Issue 2, Page(s) e15

    MeSH term(s) Antirheumatic Agents/therapeutic use ; COVID-19 ; Humans ; Prevalence ; Rheumatic Diseases/drug therapy ; Rheumatic Diseases/epidemiology ; SARS-CoV-2 ; Synthetic Drugs/therapeutic use
    Chemical Substances Antirheumatic Agents ; Synthetic Drugs
    Keywords covid19
    Language English
    Publishing date 2020-05-15
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 7090-7
    ISSN 1468-2060 ; 0003-4967
    ISSN (online) 1468-2060
    ISSN 0003-4967
    DOI 10.1136/annrheumdis-2020-217738
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Response to: 'Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab' by Schulze-Koops

    Monti, Sara / Montecucco, Carlomaurizio

    Annals of the rheumatic diseases

    2020  Volume 80, Issue 5, Page(s) e68

    MeSH term(s) Antirheumatic Agents/adverse effects ; COVID-19 ; Humans ; Rheumatic Diseases/drug therapy ; Rituximab/therapeutic use ; SARS-CoV-2
    Chemical Substances Antirheumatic Agents ; Rituximab (4F4X42SYQ6)
    Keywords covid19
    Language English
    Publishing date 2020-06-26
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 7090-7
    ISSN 1468-2060 ; 0003-4967
    ISSN (online) 1468-2060
    ISSN 0003-4967
    DOI 10.1136/annrheumdis-2020-218148
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Diagnostic and therapeutic challenges for patients with ANCA-associated vasculitides at the time of COVID-19. Response to: 'Rituximab for granulomatosis with polyangiitis in the pandemic of COVID-19: lessons from a case with severe pneumonia' by Guilpain

    Monti, Sara / Montecucco, Carlomaurizio

    Annals of the rheumatic diseases

    2020  Volume 80, Issue 1, Page(s) e11

    MeSH term(s) Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/drug therapy ; COVID-19 ; Granulomatosis with Polyangiitis/drug therapy ; Humans ; Pandemics ; Rituximab/therapeutic use ; SARS-CoV-2
    Chemical Substances Rituximab (4F4X42SYQ6)
    Keywords covid19
    Language English
    Publishing date 2020-04-30
    Publishing country England
    Document type Journal Article ; Comment
    ZDB-ID 7090-7
    ISSN 1468-2060 ; 0003-4967
    ISSN (online) 1468-2060
    ISSN 0003-4967
    DOI 10.1136/annrheumdis-2020-217555
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: 'Does hydroxychloroquine prevent the transmission of COVID-19?' by Heldwein and Calado and 'SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment' by Joob and Wiwanitkit.

    Monti, Sara / Montecucco, Carlomaurizio

    Annals of the rheumatic diseases

    2020  Volume 79, Issue 6, Page(s) e62

    MeSH term(s) Antirheumatic Agents ; Betacoronavirus ; COVID-19 ; Coronavirus Infections ; Humans ; Hydroxychloroquine ; Pandemics ; Pneumonia, Viral ; Rheumatic Diseases ; SARS-CoV-2
    Chemical Substances Antirheumatic Agents ; Hydroxychloroquine (4QWG6N8QKH)
    Keywords covid19
    Language English
    Publishing date 2020-04-23
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 7090-7
    ISSN 1468-2060 ; 0003-4967
    ISSN (online) 1468-2060
    ISSN 0003-4967
    DOI 10.1136/annrheumdis-2020-217524
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top